Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ 358,790	$ (225,214)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	5,018	46,297
Bad debt	$ 22,000	2,500
Interest receivable		(4,200)
Write-off of inventories	$ 8,206	$ 69,489
Forgiveness of note receivable - Wellington	62,900
Increase (decrease) in cash flows as a result of changes in net assets and liabilities balances:
Accounts receivable	(367,032)	$ (114,412)
Inventories	(101,429)	33,701
Prepaid expenses and other current assets	(5,972)	$ 10,077
Other assets	(380)
Accounts payable	121,043	$ 21,875
Accrued expenses and other current liabilities	(91,795)	111,832
Customer deposit	74,332	$ 690
Due to shareholder	63,843
Net cash (used in) provided operating activities	$ 149,524	$ (47,365)
Cash flows from investing activities:
Repayment from related party		11,916
Restricted cash	$ (261)	(482)
Exercise of options		$ 25,000
Other assets-investment in Angiodroid	$ (1,000)
Net cash provided (used in) by investing activities	(1,261)	$ 36,434
Cash flows used in financing activities:
Repayments on note payable - Bank	(15,024)	(11,000)
Net cash used in financing activities	(15,024)	(11,000)
Net increase (decrease) in cash and cash equivalents	133,239	(21,931)
Cash and cash equivalents - beginning of year	83,156	105,087
Cash and cash equivalents - end of year	216,395	83,156
Cash paid for:
Interest	$ 2,797	$ 2,842